METASTATIC UVEAL MELANOMA
Clinical trials for METASTATIC UVEAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UVEAL MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC UVEAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Hard-to-Treat cancers: drug combo trial launches
Disease control OngoingThis early-stage trial tests several new drug combinations in people with advanced solid tumors that have not responded to standard treatments. The goal is to find safe doses and see if these combinations can shrink tumors or slow their growth. About 352 participants with cancers…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:10 UTC
-
New hope for rare eye cancer: drug targets tumor growth
Disease control OngoingThis study tests a drug called vorinostat in 40 people with uveal melanoma that has spread to other parts of the body. Vorinostat works by blocking certain enzymes that cancer cells need to grow. The goal is to see if the drug can shrink or control the tumors, and to track how lo…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:03 UTC
-
New combo therapy shows promise for rare eye cancer
Disease control OngoingThis study tests whether combining two drugs, pembrolizumab and lenvatinib, can help people with a rare eye cancer (uveal melanoma) that has spread. About 51 adults will take part, split into two groups: those who have not had a prior treatment called tebentafusp, and those who h…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New hope for rare eye cancer: drug duo targets advanced melanoma
Disease control OngoingThis study tests a new combination of two drugs, IDE196 and crizotinib, against standard treatments for people with a rare eye cancer (uveal melanoma) that has spread to other parts of the body. Participants must have a specific genetic marker (HLA-A2 negative) and not have recei…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2, PHASE3 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New hope for eye cancer patients with liver spread: targeted chemo shows promise
Disease control OngoingThis study tests a procedure called chemoembolization for people with uveal melanoma (a type of eye cancer) that has spread to the liver. Doctors inject a chemotherapy drug directly into the liver's blood supply and block the flow to trap the drug near the tumors. The goal is to …
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New drug combo shows promise against rare eye cancer
Disease control OngoingThis study tests whether two drugs, binimetinib and belinostat, can shrink or stop the growth of metastatic uveal melanoma, a rare eye cancer that has spread. Seven adults with this condition are participating. The goal is to see if the combination works better than current treat…
Matched conditions: METASTATIC UVEAL MELANOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 19, 2026 11:48 UTC